- Partner Noah Leiden discusses the challenges of compliance specifically across healthcare organizations
- For life sciences companies seeking market access for their technology, it is imperative to understand how to effectively engage hospital procurement stakeholders.
- Dr. Jim Cross talks about why he recommends Baker Tilly healthcare as a company that makes it more understandable and easier for the client to reach their goals.
- Baker Tilly Capital, LLC's Life sciences M&A newsletter provides an overview of the current industry's marketplace, highlighting key trends impacting performance and U.S. M&A activity.
- Baker Tilly’s international tax professionals discuss the role of IP migration for life sciences companies.